StockData
Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3057% below fair value
$0.65−0.02 (-2.98%)

Close on Nov 13, 2026Market cap $32.65MP/E –Yield –

Rapid Micro Biosystems profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Rapid Micro Biosystems's profit margin for the twelve months ending Jun 30, 2026 was -145.6%. For fiscal 2025 it was -140.3%, against -167.2% the year before. The highest annual figure on record is -140.3% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-140.3%+26.9
FY2024Dec 31, 2024-167.2%+65.8
FY2023Dec 31, 2023-233.0%+121.9
FY2022Dec 31, 2022-354.9%−38.4
FY2021Dec 31, 2021-316.5%−85.8
FY2020Dec 31, 2020-230.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-160.5%+2.8
Q1 FY2026Mar 31, 2026-178.4%−22.1
Q4 FY2025Dec 31, 2025-110.8%+6.9
Q3 FY2025Sep 30, 2025-146.8%+2.1
Q2 FY2025Jun 30, 2025-163.3%+26.8
Q1 FY2025Mar 31, 2025-156.3%+81.1
Q4 FY2024Dec 31, 2024-117.6%+58.7
Q3 FY2024Sep 30, 2024-148.9%+69.0
Q2 FY2024Jun 30, 2024-190.1%+90.2
Q1 FY2024Mar 31, 2024-237.4%+38.4
Q4 FY2023Dec 31, 2023-176.3%+199.7
Q3 FY2023Sep 30, 2023-217.9%+126.8
Q2 FY2023Jun 30, 2023-280.2%+58.9
Q1 FY2023Mar 31, 2023-275.8%+83.1
Q4 FY2022Dec 31, 2022-376.0%−95.6
Q3 FY2022Sep 30, 2022-344.8%+17.4
Q2 FY2022Jun 30, 2022-339.1%−146.1
Q1 FY2022Mar 31, 2022-358.9%+83.6
Q4 FY2021Dec 31, 2021-280.4%−64.0
Q3 FY2021Sep 30, 2021-362.2%−200.9
Q2 FY2021Jun 30, 2021-193.0%+164.4
Q1 FY2021Mar 31, 2021-442.5%–
Q4 FY2020Dec 31, 2020-216.5%–
Q3 FY2020Sep 30, 2020-161.3%–
Q2 FY2020Jun 30, 2020-357.4%–

More Rapid Micro Biosystems figures

See a number that looks wrong?